Outset Medical, Inc. Increase (Decrease) in Employee Related Liabilities
Outset Medical, Inc. (OM) reported Increase (Decrease) in Employee Related Liabilities of -$1.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-06
- Outset Medical, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $318.00K, a 79.44% decline year-over-year.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$1.98M.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$120.00K, a 105.71% decline year-over-year.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $1.07M, a 67.58% decline year-over-year.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was -$6.09M.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was -$1.89M.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was -$2.52M.
- Outset Medical, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was -$3.43M, a 142.31% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.66M 10-Q · filed 2026-08-06 | -$1.78M derived: sum of 3 quarters · filed 2026-08-06 | -$716.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.98M 10-Q · filed 2026-05-07 | -$2.10M derived: sum of 2 quarters · filed 2026-05-07 | -$1.03M derived: sum of 3 quarters · filed 2026-05-07 | $513.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $946.00K derived: sum of 2 quarters · filed 2026-02-13 | $2.49M derived: sum of 3 quarters · filed 2026-08-06 | -$6.09M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.61M derived: sum of 2 quarters · filed 2026-08-06 | -$5.97M 10-Q · filed 2025-11-10 | -$3.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.03M 10-Q · filed 2026-08-06 | -$4.93M derived: sum of 3 quarters · filed 2026-08-06 | -$1.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$8.58M 10-Q · filed 2026-05-07 | -$6.48M derived: sum of 2 quarters · filed 2026-05-07 | -$3.19M derived: sum of 3 quarters · filed 2026-05-07 | -$6.01M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.39M derived: sum of 2 quarters · filed 2026-02-13 | $2.57M derived: sum of 3 quarters · filed 2026-02-13 | -$1.89M 10-K · filed 2026-02-13 |
| 2024-09-30 | $3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $471.00K derived: sum of 2 quarters · filed 2025-11-10 | -$3.99M 10-Q · filed 2025-11-10 | -$6.53M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$7.28M 10-Q · filed 2025-08-07 | -$9.82M derived: sum of 3 quarters · filed 2026-02-13 | -$5.74M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$4.46M 10-Q · filed 2025-05-08 | -$7.00M derived: sum of 2 quarters · filed 2026-02-13 | -$2.92M derived: sum of 3 quarters · filed 2026-02-13 | $123.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.54M derived: sum of 2 quarters · filed 2026-02-13 | $4.58M derived: sum of 3 quarters · filed 2026-02-13 | -$2.52M 10-K · filed 2026-02-13 |
| 2023-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $7.13M derived: sum of 2 quarters · filed 2024-11-07 | $25.00K 10-Q · filed 2024-11-07 | $2.27M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.06M 10-Q · filed 2024-08-08 | -$1.81M derived: sum of 3 quarters · filed 2025-02-28 | $1.67M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$7.10M 10-Q · filed 2024-05-09 | -$4.85M derived: sum of 2 quarters · filed 2025-02-28 | -$1.38M derived: sum of 3 quarters · filed 2025-02-28 | $942.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $5.72M derived: sum of 2 quarters · filed 2025-02-28 | $8.04M derived: sum of 3 quarters · filed 2025-02-28 | -$3.43M 10-K · filed 2025-02-28 |
| 2022-09-30 | $3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.79M derived: sum of 2 quarters · filed 2023-11-08 | -$5.67M 10-Q · filed 2023-11-08 | $1.51M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$9.15M 10-Q · filed 2023-08-03 | -$1.96M derived: sum of 3 quarters · filed 2024-02-21 | $488.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$11.47M 10-Q · filed 2023-05-04 | -$4.28M derived: sum of 2 quarters · filed 2024-02-21 | -$1.83M derived: sum of 3 quarters · filed 2024-02-21 | $877.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $9.64M derived: sum of 2 quarters · filed 2024-02-21 | $12.35M derived: sum of 3 quarters · filed 2024-02-21 | $8.10M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.16M derived: sum of 2 quarters · filed 2022-11-09 | $913.00K 10-Q · filed 2022-11-09 | $6.91M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$1.54M 10-Q · filed 2022-08-02 | $4.46M derived: sum of 3 quarters · filed 2023-02-13 | $7.30M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | -$4.24M 10-Q · filed 2022-05-05 | $1.75M derived: sum of 2 quarters · filed 2023-02-13 | $4.59M derived: sum of 3 quarters · filed 2023-02-13 | $8.37M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $8.83M derived: sum of 2 quarters · filed 2023-02-13 | $12.62M derived: sum of 3 quarters · filed 2023-02-13 | $9.89M 10-K · filed 2023-02-13 |
| 2020-09-30 | $2.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.62M derived: sum of 2 quarters · filed 2021-11-04 | $3.89M 10-Q · filed 2021-11-04 | $6.02M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.05M 10-Q · filed 2021-08-06 | $3.18M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2020-03-31 | -$2.73M 10-Q · filed 2021-05-06 | -$598.00K derived: sum of 2 quarters · filed 2022-02-23 | ||
| 2019-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.12M 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $991.00K 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $647.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |